Research libraryMOLEKUL / SOURCE RECORD

Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.

Konstantinopolsky MA, Chernyakova IV, Kolik LG · 2022 · Bulletin of experimental biology and medicine

Animal / experimentalEnglish abstractSource linked

Reported findings and study design

Rat morphine-withdrawal model; single IP Selank 0.3 mg/kg versus diazepam 2 mg/kg.

Dose, route and schedule

Single intraperitoneal Selank dose of 0.3 mg/kg; diazepam comparator 2 mg/kg.

Protocol source ↗ · Indexed abstract

Reported findings and study figures · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Total withdrawal index reduction39.6% Selank versus 49.3% diazepam
Tactile sensitivity thresholdNinefold versus thirteenfold increase
Convulsions, ptosis and posture disordersAttenuation reported with Selankp<0.0001

Animal dependence model; no human withdrawal regimen or efficacy is established.

Source for the extracted data ↗ · Checked 2026-10-29

Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.

Methods, limitations & source review

Study limitations

  • Animal and laboratory findings do not establish benefit in people.
  • Indexed abstract reviewed; complete methods, sample-size details and adverse-event tables have not been assessed.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Review depth: Indexed abstract checked

Source access and review scope

Publication metadata and indexed abstract checked through Europe PMC on 28 October 2026; full text not appraised.

Recorded source-check date: 2026-10-28. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.1007/s10517-022-05624-x

Citation and original source

Original source: Konstantinopolsky MA, Chernyakova IV, Kolik LG. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bulletin of experimental biology and medicine 2022.

Molekul research summary: https://molekul.io/research/oct28-36322304. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards